[{"address1": "142 West 57th Street", "address2": "11th Floor", "city": "New York", "state": "NY", "zip": "10019", "country": "United States", "phone": "(646) 828-8258", "website": "https://ibs.inc", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.", "fullTimeEmployees": 51, "maxAge": 86400, "priceHint": 4, "previousClose": 1.865, "open": 1.83, "dayLow": 1.82, "dayHigh": 1.98, "regularMarketPreviousClose": 1.865, "regularMarketOpen": 1.83, "regularMarketDayLow": 1.82, "regularMarketDayHigh": 1.98, "beta": 4.758, "forwardPE": -1.4560001, "volume": 61391, "regularMarketVolume": 61391, "averageVolume": 62620, "averageVolume10days": 54380, "averageDailyVolume10Day": 54380, "bid": 1.78, "ask": 1.89, "bidSize": 100, "askSize": 100, "marketCap": 5673031, "fiftyTwoWeekLow": 1.81, "fiftyTwoWeekHigh": 39.48, "priceToSalesTrailing12Months": 2.0066667, "fiftyDayAverage": 2.4342, "twoHundredDayAverage": 4.736245, "currency": "USD", "enterpriseValue": -2926273, "floatShares": 2876119, "sharesOutstanding": 3117050, "sharesShort": 78428, "sharesShortPriorMonth": 73488, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0252, "heldPercentInsiders": 0.01455, "heldPercentInstitutions": 0.22038001, "shortRatio": 1.1, "shortPercentOfFloat": 0.0252, "impliedSharesOutstanding": 3117050, "bookValue": 3.821, "priceToBook": 0.4763151, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -10031433, "trailingEps": -29.56, "forwardEps": -1.25, "lastSplitFactor": "1:12", "lastSplitDate": 1706486400, "enterpriseToRevenue": -1.035, "enterpriseToEbitda": 0.316, "52WeekChange": -0.9452467, "SandP52WeekChange": 0.26238096, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "INBS", "underlyingSymbol": "INBS", "shortName": "Intelligent Bio Solutions Inc.", "longName": "Intelligent Bio Solutions Inc.", "firstTradeDateEpochUtc": 1608733800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "94c16250-bd73-3580-bce0-15bb85c0fbbb", "messageBoardId": "finmb_578948353", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.82, "targetHighPrice": 12.0, "targetLowPrice": 12.0, "targetMeanPrice": 12.0, "targetMedianPrice": 12.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 9397523, "totalCashPerShare": 3.015, "ebitda": -9253270, "totalDebt": 933478, "quickRatio": 1.781, "currentRatio": 2.019, "totalRevenue": 2827092, "debtToEquity": 8.488, "revenuePerShare": 3.292, "returnOnAssets": -0.45618, "returnOnEquity": -1.18962, "freeCashflow": -3198371, "operatingCashflow": -7211893, "revenueGrowth": 0.802, "grossMargins": 0.23333, "operatingMargins": -3.5854998, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]